Literature DB >> 28233916

Iron accumulation and dysregulation in the putamen in fragile X-associated tremor/ataxia syndrome.

Jeanelle Ariza1, Hailee Rogers1, Anna Hartvigsen1, Melissa Snell1, Michael Dill1, Derek Judd1, Paul Hagerman2,3, Verónica Martínez-Cerdeño1,2.   

Abstract

BACKGROUND: Fragile X-associated tremor/ataxia syndrome is an adult-onset disorder associated with premutation alleles of the FMR1 gene. This disorder is characterized by progressive action tremor, gait ataxia, and cognitive decline. Fragile X-associated tremor/ataxia syndrome pathology includes dystrophic white matter and intranuclear inclusions in neurons and astrocytes. We previously demonstrated that the transport of iron into the brain is altered in fragile X-associated tremor/ataxia syndrome; therefore, we also expect an alteration of iron metabolism in brain areas related to motor control. Iron is essential for cell metabolism, but uncomplexed iron leads to oxidative stress and contributes to the development of neurodegenerative diseases. We investigated a potential iron modification in the putamen - a structure that participates in motor learning and performance - in fragile X-associated tremor/ataxia syndrome.
METHODS: We used samples of putamen obtained from 9 fragile X-associated tremor/ataxia syndrome and 9 control cases to study iron localization using Perl's method, and iron-binding proteins using immunostaining.
RESULTS: We found increased iron deposition in neuronal and glial cells in the putamen in fragile X-associated tremor/ataxia syndrome. We also found a generalized decrease in the amount of the iron-binding proteins transferrin and ceruloplasmin, and decreased number of neurons and glial cells that contained ceruloplasmin. However, we found increased levels of iron, transferrin, and ceruloplasmin in microglial cells, indicating an attempt by the immune system to remove the excess iron.
CONCLUSIONS: Overall, found a deficit in proteins that eliminate extra iron from the cells with a concomitant increase in the deposit of cellular iron in the putamen in Fragile X-associated tremor/ataxia syndrome.
© 2017 International Parkinson and Movement Disorder Society. © 2017 International Parkinson and Movement Disorder Society.

Entities:  

Keywords:  CGG; FXTAS; dementia; fragile X; motor disorder; neurodegeneration; repeat-expansion disorder

Mesh:

Substances:

Year:  2017        PMID: 28233916      PMCID: PMC5714315          DOI: 10.1002/mds.26902

Source DB:  PubMed          Journal:  Mov Disord        ISSN: 0885-3185            Impact factor:   10.338


  35 in total

1.  Intranuclear inclusions in neural cells with premutation alleles in fragile X associated tremor/ataxia syndrome.

Authors:  F Tassone; R J Hagerman; D Garcia-Arocena; E W Khandjian; C M Greco; P J Hagerman
Journal:  J Med Genet       Date:  2004-04       Impact factor: 6.318

2.  Autism spectrum disorders and attention-deficit/hyperactivity disorder in boys with the fragile X premutation.

Authors:  Faraz Farzin; Hazel Perry; David Hessl; Danuta Loesch; Jonathan Cohen; Susan Bacalman; Louise Gane; Flora Tassone; Paul Hagerman; Randi Hagerman
Journal:  J Dev Behav Pediatr       Date:  2006-04       Impact factor: 2.225

3.  A Majority of FXTAS Cases Present with Intranuclear Inclusions Within Purkinje Cells.

Authors:  Jeanelle Ariza; Hailee Rogers; Angela Monterrubio; Adriana Reyes-Miranda; Paul J Hagerman; Verónica Martínez-Cerdeño
Journal:  Cerebellum       Date:  2016-10       Impact factor: 3.847

4.  Elevated Fmr1 mRNA levels and reduced protein expression in a mouse model with an unmethylated Fragile X full mutation.

Authors:  J R Brouwer; E J Mientjes; C E Bakker; I M Nieuwenhuizen; L A Severijnen; H C Van der Linde; D L Nelson; B A Oostra; R Willemsen
Journal:  Exp Cell Res       Date:  2006-10-13       Impact factor: 3.905

Review 5.  Iron deficiency alters brain development and functioning.

Authors:  John Beard
Journal:  J Nutr       Date:  2003-05       Impact factor: 4.798

6.  Expanded clinical phenotype of women with the FMR1 premutation.

Authors:  Sarah M Coffey; Kylee Cook; Nicole Tartaglia; Flora Tassone; Danh V Nguyen; Ruiqin Pan; Hannah E Bronsky; Jennifer Yuhas; Mariya Borodyanskaya; Jim Grigsby; Melanie Doerflinger; Paul J Hagerman; Randi J Hagerman
Journal:  Am J Med Genet A       Date:  2008-04-15       Impact factor: 2.802

7.  Impact of the Fragile X mental retardation 1 (FMR1) gene premutation on neuropsychiatric functioning in adult males without fragile X-associated Tremor/Ataxia syndrome: a controlled study.

Authors:  Cary S Kogan; Jeremy Turk; Randi J Hagerman; Kim M Cornish
Journal:  Am J Med Genet B Neuropsychiatr Genet       Date:  2008-09-05       Impact factor: 3.568

8.  Clinical and neuropathologic findings in a woman with the FMR1 premutation and multiple sclerosis.

Authors:  Claudia M Greco; Flora Tassone; Dolores Garcia-Arocena; Nicole Tartaglia; Sarah M Coffey; Timothy K Vartanian; James A Brunberg; Paul J Hagerman; Randi J Hagerman
Journal:  Arch Neurol       Date:  2008-08

Review 9.  Neurodegeneration with Brain Iron Accumulation.

Authors:  Susanne A Schneider
Journal:  Curr Neurol Neurosci Rep       Date:  2016-01       Impact factor: 5.081

10.  Fragile X-associated tremor/ataxia syndrome: influence of the FMR1 gene on motor fiber tracts in males with normal and premutation alleles.

Authors:  Jun Yi Wang; David Hessl; Andrea Schneider; Flora Tassone; Randi J Hagerman; Susan M Rivera
Journal:  JAMA Neurol       Date:  2013-08       Impact factor: 18.302

View more
  14 in total

1.  Microglial cell activation and senescence are characteristic of the pathology FXTAS.

Authors:  Verónica Martínez Cerdeño; Tiffany Hong; Sarwat Amina; Mirna Lechpammer; Jeanelle Ariza; Flora Tassone; Stephen C Noctor; Paul Hagerman; Randi Hagerman
Journal:  Mov Disord       Date:  2018-12-10       Impact factor: 10.338

2.  Cortical interlaminar astrocytes across the therian mammal radiation.

Authors:  Carmen Falcone; Marisol Wolf-Ochoa; Sarwat Amina; Tiffany Hong; Gelareh Vakilzadeh; William D Hopkins; Patrick R Hof; Chet C Sherwood; Paul R Manger; Stephen C Noctor; Verónica Martínez-Cerdeño
Journal:  J Comp Neurol       Date:  2019-01-25       Impact factor: 3.215

3.  Altered mitochondrial function in cells carrying a premutation or unmethylated full mutation of the FMR1 gene.

Authors:  Veronica Nobile; Federica Palumbo; Stella Lanni; Valentina Ghisio; Alberto Vitali; Massimo Castagnola; Valeria Marzano; Giuseppe Maulucci; Claudio De Angelis; Marco De Spirito; Laura Pacini; Laura D'Andrea; Rino Ragno; Giulia Stazi; Sergio Valente; Antonello Mai; Pietro Chiurazzi; Maurizio Genuardi; Giovanni Neri; Elisabetta Tabolacci
Journal:  Hum Genet       Date:  2020-01-09       Impact factor: 4.132

4.  Interaction between ventricular expansion and structural changes in the corpus callosum and putamen in males with FMR1 normal and premutation alleles.

Authors:  Jun Yi Wang; David Hessl; Flora Tassone; Kyoungmi Kim; Randi J Hagerman; Susan M Rivera
Journal:  Neurobiol Aging       Date:  2019-09-24       Impact factor: 4.673

5.  FXTAS presents with upregulation of the cytokines IL12 and TNFα.

Authors:  Brett D Dufour; Sarwat Amina; Veronica Martinez-Cerdeno
Journal:  Parkinsonism Relat Disord       Date:  2020-11-30       Impact factor: 4.891

Review 6.  Fragile X syndrome and associated disorders: Clinical aspects and pathology.

Authors:  Maria Jimena Salcedo-Arellano; Brett Dufour; Yingratana McLennan; Veronica Martinez-Cerdeno; Randi Hagerman
Journal:  Neurobiol Dis       Date:  2020-01-10       Impact factor: 7.046

7.  Precision Sensorimotor Control in Aging FMR1 Gene Premutation Carriers.

Authors:  Walker S McKinney; Zheng Wang; Shannon Kelly; Pravin Khemani; Su Lui; Stormi P White; Matthew W Mosconi
Journal:  Front Integr Neurosci       Date:  2019-10-02

8.  Rapidly Progressing Neurocognitive Disorder in a Male with FXTAS and Alzheimer's Disease.

Authors:  Elber Yuksel Aydin; Andrea Schneider; Dragana Protic; Jun Yi Wang; Veronica Martínez-Cerdeño; Flora Tassone; Hiu-Tung Tang; Susan Perlman; Randi J Hagerman
Journal:  Clin Interv Aging       Date:  2020-02-26       Impact factor: 4.458

9.  Ataxia as the Major Manifestation of Fragile X-Associated Tremor/Ataxia Syndrome (FXTAS): Case Series.

Authors:  Maria Jimena Salcedo-Arellano; Ana Maria Cabal-Herrera; Nattaporn Tassanakijpanich; Yingratana A McLennan; Randi J Hagerman
Journal:  Biomedicines       Date:  2020-05-25

10.  Presence of Middle Cerebellar Peduncle Sign in FMR1 Premutation Carriers Without Tremor and Ataxia.

Authors:  Jessica L Famula; Forrest McKenzie; Yingratana A McLennan; James Grigsby; Flora Tassone; David Hessl; Susan M Rivera; Veronica Martinez-Cerdeno; Randi J Hagerman
Journal:  Front Neurol       Date:  2018-08-22       Impact factor: 4.003

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.